Beihua Kong

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Long Noncoding Rna

Top Venues

Cell death & disease

Cell death discovery

Journal of hematology & oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yingwei Li, Zhongshao Chen, Jiali Peng, Cunzhong Yuan, Shi Yan, Ning Yang, Peng Li, Beihua Kong
The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2. Oncogene (2023)
Hanlin Ma, Gonghua Qi, Fang Han, Jiali Peng, Cunzhong Yuan, Beihua Kong
PBK drives PARP inhibitor resistance through the TRIM37/NFκB axis in ovarian cancer. Experimental & molecular medicine 54 (7) (2022)
Yuchao Diao, Yingwei Li, Zixiang Wang, Shourong Wang, Peng Li, Beihua Kong
SF3B4 promotes ovarian cancer progression by regulating alternative splicing of RAD52. Cell death & disease 13 (2) (2022)
Fangfang Li, Chen Zhao, Yuchao Diao, Zixiang Wang, Jiali Peng, Ning Yang, Chunping Qiu, Beihua Kong, Yingwei Li
MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS. Cell death & disease 13 (6) (2022)
Hanlin Ma, Gonghua Qi, Fang Han, Wei Lu, Jiali Peng, Rongrong Li, Shi Yan, Cunzhong Yuan, Beihua Kong
HMGB3 promotes PARP inhibitor resistance through interacting with PARP1 in ovarian cancer. Cell death & disease 13 (3) (2022)
Yingwei Li, Yuchao Diao, Zixiang Wang, Shourong Wang, Jiali Peng, Beihua Kong
The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5. Cell death discovery 8 (1) (2022)
Gonghua Qi, Hanlin Ma, Yingwei Li, Jiali Peng, Jingying Chen, Beihua Kong
TTK inhibition increases cisplatin sensitivity in high-grade serous ovarian carcinoma through the mTOR/autophagy pathway. Cell death & disease 12 (12) (2021)
Chenggong Sun, Wenyu Cao, Chunping Qiu, Chengcheng Li, Samina Dongol, Zhiwei Zhang, Ruifen Dong, Kun Song, Xingsheng Yang, Qing Zhang, Beihua Kong
MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC. Journal of hematology & oncology 13 (1) (2020)